Chad Cowan - Oct 1, 2024 Form 3 Insider Report for Century Therapeutics, Inc. (IPSC)

Role
Chief Scientific Officer
Signature
/s/ Douglas Carr, Attorney-in-Fact
Stock symbol
IPSC
Transactions as of
Oct 1, 2024
Transactions value $
$0
Form type
3
Date filed
10/3/2024, 06:04 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IPSC Common Stock 136K Oct 1, 2024 Direct
holding IPSC Common Stock 10.7K Oct 1, 2024 By Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by the Cowan Investment Nominee Trust. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.

Remarks:

Exhibit 24 - Power of Attorney